Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2020-02-14 2020-02-14
Drug Identification Number 02456532 02456532
Brand name BEPREVE BEPREVE
Common or Proper name BEPREVE BEPREVE
Company Name BAUSCH & LOMB INC BAUSCH & LOMB INC
Ingredients BEPOTASTINE BESILATE BEPOTASTINE BESILATE
Strength(s) 1.5% 1.5%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 10ml 10ml
ATC code S01 S01
ATC description L3 not assigned L3 not assigned
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2019-11-15 2019-11-15
Estimated end date
Actual end date 2020-02-11 2020-02-11
Shortage status Resolved Resolved
Company comments artwork issue artwork issue
Health Canada comments